• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国 1998-2007 年产妇死亡保密性调查十年

Ten years of confidential inquiries into maternal deaths in France, 1998-2007.

机构信息

INSERM U953, Epidemiological Research Unit on Perinatal Health and Women's and Children's Health, Paris, France.

出版信息

Obstet Gynecol. 2013 Oct;122(4):752-760. doi: 10.1097/AOG.0b013e31829fc38c.

DOI:10.1097/AOG.0b013e31829fc38c
PMID:24084531
Abstract

OBJECTIVE

To assess trends in the maternal mortality ratio over a 10-year period in France and the causes, risk factors, quality of care, and avoidability of maternal deaths.

METHODS

Maternal deaths up to 1 year after the end of the pregnancy from 1998 to 2007 were identified and studied through the French Confidential Enquiry Into Maternal Deaths system. Time trends were analyzed by comparing the two 5-year periods for maternal mortality ratios, both overall and by women's characteristics, causes of death, existence of suboptimal care, and avoidability.

RESULTS

For the 10-year period, 660 maternal deaths were identified. The maternal mortality ratio was similar in the two 5-year periods, 8.8 per 100,000 live births (95% confidence interval [CI] 7.8-9.8) for 1998-2002 and 8.4 per 100,000 live births (95% CI 7.6-9.4) for 2003-2007. The distributions of maternal age, nationality, and of causes of death did not change. Overall, hemorrhage was the leading cause of death, responsible for 18% of maternal deaths, followed by amniotic fluid embolism, thromboembolism, hypertensive disorders, and cardiovascular conditions, each of which contributed to 10-12% of deaths. Suboptimal care decreased from 70% in 1998-2002 to 60% in 2003-2007 (P<.03). Half of all deaths were considered avoidable and this proportion did not change. The most frequent contributory factor was inadequate management.

CONCLUSION

The ratio and profile of maternal mortality in France remained unchanged from 1998 to 2007. Half of all maternal deaths are still considered avoidable, which indicates that improvement remains possible.

LEVEL OF EVIDENCE

: III.

摘要

目的

评估法国 10 年来孕产妇死亡率的变化趋势以及孕产妇死亡的原因、风险因素、医疗质量和可避免性。

方法

通过法国孕产妇死亡机密调查系统,确定了 1998 年至 2007 年期间分娩后 1 年内的孕产妇死亡病例,并对其进行了研究。通过比较两个 5 年期间的孕产妇死亡率,包括整体和按妇女特征、死亡原因、存在次优护理以及可避免性进行比较,对时间趋势进行了分析。

结果

在这 10 年期间,共确定了 660 例孕产妇死亡病例。两个 5 年期间的孕产妇死亡率相似,1998-2002 年为每 10 万活产儿 8.8 例(95%置信区间[CI]为 7.8-9.8),2003-2007 年为每 10 万活产儿 8.4 例(95% CI 为 7.6-9.4)。孕产妇年龄、国籍和死亡原因的分布没有改变。总体而言,出血是导致死亡的主要原因,占孕产妇死亡的 18%,其次是羊水栓塞、血栓栓塞、高血压疾病和心血管疾病,各占 10-12%的死亡。次优护理从 1998-2002 年的 70%下降到 2003-2007 年的 60%(P<.03)。一半的死亡被认为是可以避免的,这一比例没有改变。最常见的促成因素是管理不当。

结论

1998 年至 2007 年期间,法国的孕产妇死亡率和构成保持不变。仍有一半的孕产妇死亡被认为是可以避免的,这表明仍有可能改进。

证据水平

III 级。

相似文献

1
Ten years of confidential inquiries into maternal deaths in France, 1998-2007.法国 1998-2007 年产妇死亡保密性调查十年
Obstet Gynecol. 2013 Oct;122(4):752-760. doi: 10.1097/AOG.0b013e31829fc38c.
2
[Epidemiology of maternal mortality in France, 2010-2012].[2010 - 2012年法国孕产妇死亡率的流行病学情况]
Gynecol Obstet Fertil Senol. 2017 Dec;45(12S):S8-S21. doi: 10.1016/j.gofs.2017.10.025. Epub 2017 Nov 4.
3
[Maternal mortality in France, 2016-2018, frequency, causes and women's profile].[2016 - 2018年法国孕产妇死亡率、发生频率、原因及女性特征]
Gynecol Obstet Fertil Senol. 2024 Apr;52(4):185-200. doi: 10.1016/j.gofs.2024.02.020. Epub 2024 Feb 17.
4
[Maternal Mortality, Frequency, causes, women's profile and preventability of deaths in France, 2013-2015].[2013 - 2015年法国孕产妇死亡率、发生频率、原因、女性特征及死亡可预防性]
Gynecol Obstet Fertil Senol. 2021 Jan;49(1):9-26. doi: 10.1016/j.gofs.2020.11.006. Epub 2020 Nov 5.
5
Maternal mortality among women with sickle-cell disease in France, 1996-2009.1996 - 2009年法国镰状细胞病女性的孕产妇死亡率
Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:183-8. doi: 10.1016/j.ejogrb.2015.09.016. Epub 2015 Sep 25.
6
[Maternal mortality estimation in France, according to a new method].[根据一种新方法对法国孕产妇死亡率的估计]
J Gynecol Obstet Biol Reprod (Paris). 2004 Sep;33(5):421-9. doi: 10.1016/s0368-2315(04)96550-7.
7
[Analysis of maternal deaths in Shanghai from 2000 to 2009].[2000年至2009年上海孕产妇死亡情况分析]
Zhonghua Fu Chan Ke Za Zhi. 2011 Apr;46(4):244-9.
8
[The confidential enquiries into maternal deaths, 1996-2006 in France: what consequences for the obstetrical care?].[法国1996 - 2006年孕产妇死亡情况的保密调查:对产科护理有何影响?]
J Gynecol Obstet Biol Reprod (Paris). 2011 Apr;40(2):87-102. doi: 10.1016/j.jgyn.2010.12.007.
9
[Maternal deaths due to amniotic fluid embolism. Results from the French confidential enquiry into maternal deaths, 2010-2012].[羊水栓塞导致的孕产妇死亡。法国孕产妇死亡机密调查报告结果,2010 - 2012年]
Gynecol Obstet Fertil Senol. 2017 Dec;45(12S):S43-S47. doi: 10.1016/j.gofs.2017.10.014. Epub 2017 Nov 14.
10
[Maternal deaths due to infectious cause, results from the French confidential enquiry into maternal deaths, 2010-2012].[2010 - 2012年法国孕产妇死亡保密调查中因感染性病因导致的孕产妇死亡情况]
Gynecol Obstet Fertil Senol. 2017 Dec;45(12S):S48-S53. doi: 10.1016/j.gofs.2017.10.016. Epub 2017 Nov 3.

引用本文的文献

1
Differential risk and clinical characteristics of placenta accreta spectrum in twin and singleton pregnancies: implications for perinatal outcomes.双胎妊娠与单胎妊娠胎盘植入谱系的差异风险及临床特征:对围产期结局的影响
J Glob Health. 2025 Aug 22;15:04252. doi: 10.7189/jogh.15.04252.
2
Study protocol. TRAAPREVIA-TRAnexamic acid for preventing blood loss following a cesarean delivery in women with a placenta pREVIA or low-lying placenta: a multicenter randomized, double blind, placebo controlled trial.研究方案。TRAAPREVIA——氨甲环酸预防前置胎盘或低置胎盘女性剖宫产术后失血:一项多中心随机、双盲、安慰剂对照试验。
BMC Pregnancy Childbirth. 2025 May 30;25(1):635. doi: 10.1186/s12884-025-07682-1.
3
Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k, AWMF Registry No. 015-063, August 2022).
围产期出血的诊断与治疗。德国妇产科学会、奥地利妇产科学会和瑞士妇产科学会指南(S2k,德国医学专业协会注册编号015 - 063,2022年8月)
Geburtshilfe Frauenheilkd. 2023 Jun 28;83(12):1446-1490. doi: 10.1055/a-2073-9615. eCollection 2023 Dec.
4
Situations in Which Oxytocin Was Administrated by Paramedics in Out-of-Hospital Births: A Retrospective Analysis over Six Years in the Polish Population.护理人员在院外分娩中使用催产素的情况:波兰人群六年回顾性分析
J Clin Med. 2024 Nov 26;13(23):7175. doi: 10.3390/jcm13237175.
5
Maternal mortality due to obstetric hemorrhage by surgical injury during cesarean section: A nationwide study.剖宫产术中外科损伤导致的产科出血所致产妇死亡:一项全国性研究。
Acta Obstet Gynecol Scand. 2024 Sep;103(9):1877-1887. doi: 10.1111/aogs.14917. Epub 2024 Jul 18.
6
Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and a placenta previa or low lying: a prospective population-based study.有剖宫产史且合并前置胎盘或胎盘低置的孕妇发生胎盘植入谱系疾病的危险因素:一项前瞻性基于人群的研究。
Sci Rep. 2024 Mar 19;14(1):6564. doi: 10.1038/s41598-024-56964-9.
7
Obstetric Point of Care Echocardiography.产科床旁超声心动图
Kans J Med. 2022 Dec 19;15(3):441-442. doi: 10.17161/kjm.vol15.18439. eCollection 2022.
8
Maternal mortality in women with pre-viable premature rupture of membranes: An analysis from the French confidential enquiry into maternal deaths.未足月胎膜早破孕妇的孕产妇死亡率:来自法国孕产妇死亡机密调查的分析。
Acta Obstet Gynecol Scand. 2022 Dec;101(12):1395-1402. doi: 10.1111/aogs.14452. Epub 2022 Oct 7.
9
Maternal sudden death: A nationwide retrospective study.产妇突然死亡:一项全国性回顾性研究。
BJOG. 2023 Feb;130(3):257-263. doi: 10.1111/1471-0528.17294. Epub 2022 Oct 9.
10
Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study.胎盘植入谱系疾病 - 英国和法国临床实践和产妇发病率的差异:基于人群的比较研究。
BJOG. 2022 Sep;129(10):1676-1685. doi: 10.1111/1471-0528.17169. Epub 2022 Apr 29.